Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$19.51 - $24.28 $10,184 - $12,674
-522 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$21.47 - $37.33 $10,284 - $17,881
479 Added 1113.95%
522 $12,000
Q1 2019

May 13, 2019

SELL
$28.4 - $36.49 $710 - $912
-25 Reduced 36.76%
43 $2,000
Q4 2018

Feb 08, 2019

BUY
$27.94 - $44.61 $1,285 - $2,052
46 Added 209.09%
68 $2,000
Q3 2018

Nov 13, 2018

SELL
$38.6 - $46.12 $2,856 - $3,412
-74 Reduced 77.08%
22 $1,000
Q2 2018

Aug 10, 2018

SELL
$40.56 - $51.36 $5,516 - $6,984
-136 Reduced 58.62%
96 $4,000
Q1 2018

May 14, 2018

BUY
$53.61 - $67.26 $2,573 - $3,228
48 Added 26.09%
232 $13,000
Q4 2017

Feb 09, 2018

BUY
$47.69 - $55.39 $6,724 - $7,809
141 Added 327.91%
184 $10,000
Q3 2017

Nov 14, 2017

BUY
$49.16 - $54.45 $2,113 - $2,341
43
43 $2,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.